Should N-Acetylcysteine be Administered Orally or Intravenously for the Treatment of Paracetamol Overdose?

Abstract

Introduction

Paracetamol is the most commonly used drug in deliberate poisoning. N-acetylcysteine is the standard antidote for significant acute paracetamol overdose, but the route of administration varies between countries. This review aimed to find and appraise those comparative studies which would help answer the following question: in patients who have taken an overdose of paracetamol requiring antidote, is there any difference between intravenous and oral N-acetylcysteine in mortality, hepatotoxicity, adverse drug reactions or cost?

Methods

A literature search was conducted using Medline and other databases. Relevant papers were identified and appraised.

Results

One animal study and seven comparative clinical studies were identified and appraised. The quality of the evidence was generally poor, and there was no clear difference in outcomes between the two routes of administration.

Conclusions

Without evidence of advantage for one route over the other, routine practice should not be changed. However, after 30 years experience, both routes appear to be effective and safe, and in countries where intravenous administration is the standard, it would be reasonable to consider the oral route as an alternative when intravenous access is problematic. There is a need for prospective, randomised trials to determine the relative effectiveness, safety and cost of intravenous and oral formulations of N-acetylcysteine.

Keywords

Acetaminophen acetylcysteine intravenous infusions oral administration

References

Prescott

Oral or intravenous N-acetylcysteine for acetaminophen poisoning?

Ann Emerg Med 2005; 45(4): 409–13.

Buckley

, Eddlestone

Paracetamol (acetaminophen) poisoning. Clin Evid 2005; 14: 1738–44.

Tsai

C.L.

, Chang

W.T.

, Weng

T.I.

, Fang

C.C.

, Chen

W.J.

Acute acetaminophen intoxication in Taiwan: outcomes and risk factors. J Formos Med Assoc 2004; 103(11): 830–5.

Chan

Y.C.

, Fung

H.T.

, Lee

C.K.

, Tsui

S.H.

, Ngan

H.K.

, Sy

M.Y.

A prospective epidemiological study of acute poisoning in Hong Kong. Hong Kong J Emerg Med 2005; 12(3): 156–61.

Morgan

, Griffiths

, Majeed

Impact of paracetamol pack size restrictions on poisoning from paracetamol in England and Wales: an observational study. J Public Health (Oxf) 2005; 27(1): 19–24.

Chan

T.Y.

, Chan

A.Y.

, Critchley

J.A.

Factors responsible for continuing morbidity after paracetamol poisoning in Chinese patients in Hong Kong. Singapore Med J 1996; 37(3): 275–7.

Perry

H.E.

, Shannon

M.W.

Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: results of an open-label, clinical trial. J Pediatr 1998; 132(1): 149–52.

Chan

T.Y.

, Chan

A.Y.

, Critchley

J.A.

Paracetamol poisoning and hepatotoxicity in Chinese - the Prince of Wales Hospital (Hong Kong) experience. Singapore Med J 1993; 34(4): 299–302.

Prescott

L.F.

, Illingworth

R.N.

, Critchley

J.A.

, Stewart

M.J.

, Adam

R.D.

, Proudfoot

A.T.

Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. BMJ 1979; 2(6198): 1097–100.

10.

Rumack

B.H.

, Peterson

R.C.

, Koch

G.G.

, Amara

I.A.

Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med 1981; 141(3 Spec No): 380–5.

11.

Brok

, Buckley

, Gluud

Interventions for paracetamol (acetaminophen) overdoses. Cochrane Database Syst Rev 2006;(2): CD003328. [2002; (3): CD003328].

12.

Spiller

H.A.

, Krenzelok

E.P.

, Grande

G.A.

, Safir

E.F.

, Diamond

J.J.

A prospective evaluation of the effect of activated charcoal before oral N-acetylcysteine in acetaminophen overdose. Ann Emerg Med 1994; 23(3): 519–23.

13.

Joint Formulary Committee. British National Formulary, 51st ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2006. p. 30.

14.

Kerr

, Dawson

, Whyte

I.M.

, Buckley

, Murray

, Graudins

The Australasian clinical toxicology investigators collaboration randomized controlled trial of different loading infusion rates of N-acetylcysteine. Ann Emerg Med 2005; 45(4): 402–8.

15.

Tsai

C.L.

, Chang

W.T.

, Weng

T.I.

, Fang

C.C.

, Walson

P.D.

A patient-tailored N-acetylcysteine protocol for acute acetaminophen intoxication. Clin Ther 2005; 27(3): 336–41.

16.

Rumack

B.H.

, Peterson

R.G.

Acetaminophen overdose: incidence, diagnosis, and management in 416 patients. Pediatrics 1978; 62(5 Pt 2 Suppl): 898–903.

17.

Smilkstein

M.J.

, Knapp

G.L.

, Kulig

K.W.

, Rumack

B.H.

Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). New Engl J Med 1988; 319(24): 1557–62.

18.

Smilkstein

M.J.

, Bronstein

A.C.

, Linden

, Augenstein

W.L.

, Kulig

K.W.

, Rumack

B.H.

Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med 1991; 20(10): 1058–63.

19.

Buckley

N.A.

, Whyte

I.M.

, O'Connell

D.L.

, Dawson

A.H.

Oral or intravenous N-acetylcysteine: which is the treatment of choice for acetaminophen (paracetamol) poisoning?

J Toxicol Clin Toxicol 1999; 37(6): 759–67.

20.

Merl

, Koutsogiannis

, Kerr

, Kelly

A.M.

How safe is intravenous N-acetylcysteine for the treatment of paracetamol poisoning?

Hong Kong J Emerg Med 2007; 14(4): 198–203.

21.

Woo

O.F.

, Mueller

P.D.

, Olson

K.R.

, Anderson

I.B.

, Kim

S.Y.

Shorter duration of oral N-acetylcysteine therapy for acute acetaminophen overdose. Ann Emerg Med 2000; 35(4): 363–8.

22.

Yarema

M.C.

, Johnson

D.W.

, Berlin

, Nettel-Aguirre

, Brant

, Sivilotti

The 72 hour oral versus the 20 hour intravenous N-acetylcysteine protocols for treatment of acute acetaminophen overdose. Clin Toxicol (Phila) 2006; 44(5): 782.

23.

Lifshitz

, Kornmehl

, Reuveni

The incidence and nature of adverse reactions during intravenous acetylcysteine therapy for acetaminophen overdose. J Pharm Technol 2000; 16(2): 44–9.

24.

Mullins

M.E.

, Schmidt

R.U.

, Jang

T.B.

What is the rate of adverse events with intravenous versus oral N-acetylcysteine in pediatric patients?

Ann Emerg Med 2004; 44(5): 547–8.

25.

Miller

M.A.

, Navarro

, Bird

S.B.

, Donovan

J.L.

Antiemetic use in acetaminophen poisoning: how does the route of N-acetylcysteine administration affect utilization?

J Med Toxicol 2007; 3(4): 152–6.

26.

Savides

M.C.

, Oehme

F.W.

, Leipold

H.W.

Effects of various antidotal treatments on acetaminophen toxicosis and biotransformation in cats. Am J Vet Res 1985; 46(7): 1485–9.

27.

National Institute for Health and Clinical Excellence. The guidelines manual. London: National Institute for Health and Clinical Excellence; 2007. p. 45–6. Available from: www.nice.org.uk

28.

Parker

, White

J.P.

, Paton

, Routledge

P.A.

Safety of late acetylcysteine treatment in paracetamol poisoning. Hum Exp Toxicol 1990; 9(1): 25–7.

29.

Ayonrinde

O.T.

, Phelps

G.J.

, Hurley

J.C.

, Ayonrinde

O.A.

Paracetamol overdose and hepatotoxicity at a regional Australian hospital: a 4-year experience. Intern Med J 2005; 35(11): 655–60.

30.

Kanter

M.Z.

Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning. Am J Health Syst Pharm 2006; 63(19) 1821–7.

31.

Wright

R.O.

, Anderson

A.C.

, Lesko

S.L.

, Woolf

A.D.

, Linakis

J.G.

, Lewander

W.J.

Effect of metoclopramide dose on preventing emesis after oral administration of N-acetylcysteine for acetaminophen overdose. J Toxicol Clin Toxicol 1999; 37(1): 35–42.

32.

Cattermole

G.N.

Oral N-acetylcysteine for acute paracetamol poisoning. [Letter] Emerg Med J 2007; 24(12): 866.